Philip E. Ryan
Impact in
-
- Ubiquitin and proteasome pathways
- Glycosylation and Glycoproteins Research
- Protein Degradation and Inhibitors
-
- Prostate Cancer Treatment and Research
Papers in
-
- Ubiquitin and proteasome pathways 9
- Glycosylation and Glycoproteins Research 8
-
- Galectins and Cancer Biology 4
- Co-authors
- Stanley Lipkowitz (8 shared papers)Marion M. Nau (5 shared papers)Santosh Rudrawar (11 shared papers)Stephen C. Kales (4 shared papers)Clifford G. Tepper (2 shared papers)Ai‐Hong Ma (1 shared paper)Hsing-Jien Kung (1 shared paper)Thomas G. Pretlow (1 shared paper)
- Journals
- ACS Chemical Neuroscience (3 papers)PLoS ONE (3 papers)Bioorganic Chemistry (2 papers)Trends in Biochemical Sciences (1 paper)Cancer Research (1 paper)
- Partner nations
- United StatesAustraliaIndia
In The Last Decade
Philip E. Ryan
23 papers receiving 886 citations
Peers
Comparison fields: 5 of 83
- Molecular Biology 539
- Pulmonary and Respiratory Medicine 183
- Cancer Research 83
- Oncology 148
- Immunology 116
Countries citing papers authored by Philip E. Ryan
This map shows the geographic impact of Philip E. Ryan's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Philip E. Ryan with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Philip E. Ryan more than expected).
Fields of papers citing papers by Philip E. Ryan
This network shows the impact of papers produced by Philip E. Ryan. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Philip E. Ryan. The network helps show where Philip E. Ryan may publish in the future.
Co-authors
The 25 scholars most cited alongside Philip E. Ryan, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 23 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Characterization of a novel androgen receptor mutation in a relapsed CWR22 prostate cancer xenograft and cell line. | 2002 | 227 |
| 2 | 2010 | 111 | |
| 3 | 2018 | 88 | |
| 4 | 2006 | 82 | |
| 5 | 2019 | 58 | |
| 6 | 2019 | 45 | |
| 7 | 2019 | 40 | |
| 8 | 2010 | 34 | |
| 9 | 2005 | 30 | |
| 10 | 2006 | 27 | |
| 11 | 2019 | 23 | |
| 12 | 2019 | 19 | |
| 13 | 2012 | 18 | |
| 14 | 2005 | 17 | |
| 15 | 2012 | 16 | |
| 16 | 2019 | 14 | |
| 17 | 2019 | 12 | |
| 18 | 2020 | 11 | |
| 19 | 2016 | 10 | |
| 20 | 2020 | 8 |
About Philip E. Ryan
Philip E. Ryan is a scholar working on Molecular Biology, Immunology, Organic Chemistry, Oncology and Neurology, having authored 23 papers that have together received 903 indexed citations. Recurring topics across this work include Ubiquitin and proteasome pathways (9 papers), Glycosylation and Glycoproteins Research (8 papers), Carbohydrate Chemistry and Synthesis (7 papers), Galectins and Cancer Biology (4 papers), Parkinson's Disease Mechanisms and Treatments (2 papers), NF-κB Signaling Pathways (2 papers), Peptidase Inhibition and Analysis (2 papers) and Cancer-related Molecular Pathways (2 papers). The work is most often cited by research in Molecular Biology (539 citations), Pulmonary and Respiratory Medicine (183 citations), Cancer Research (83 citations), Oncology (148 citations) and Immunology (116 citations). Philip E. Ryan has collaborated with scholars based in United States, Australia and India. Frequent co-authors include Stanley Lipkowitz, Marion M. Nau, Santosh Rudrawar, Stephen C. Kales, Clifford G. Tepper, Ai‐Hong Ma, Hsing-Jien Kung, Thomas G. Pretlow, Liang Xia and David L. Boucher. Their work appears in journals such as ACS Chemical Neuroscience, PLoS ONE, Bioorganic Chemistry, Trends in Biochemical Sciences and Cancer Research.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.